Free insulin‐like growth factors (IGF‐I and IGF‐II) in human serum
- 11 July 1994
- journal article
- Published by Wiley in FEBS Letters
- Vol. 348 (2) , 185-191
- https://doi.org/10.1016/0014-5793(94)00602-4
Abstract
Using ultrafiltration by centrifugation we have isolated the free, unbound fractions of insulin‐like growth factor I and II (free IGF‐I and IGF‐II) in human serum. In this way near in vivo conditions could be maintained before and during isolation. The recovery was 80 to 100% in the ultrafiltrates, which contained no detectable amounts of IGF‐binding proteins (IGFBPs) as measured by Western ligand blotting and IGFBP‐1 and IGFBP‐3 immunoassays. The concentration of free peptides was measured in two ultrasensitive non‐competitive IGF‐I and IGF‐II time‐resolved fluoroimmunoassays. We found that (i) equilibrium between free and protein‐complexed IGF was strongly dependent on re‐establishment of in vivo conditions (temperature, pH, ionic milieu and dilution); (ii) metabolic events (glucose load and fasting) caused significant changes in free IGF‐I and IGF‐II levels without concomitant changes in total circulating levels of IGFs; (iii) in 49 healthy adult subjects (20 to above 60 years) free IGF‐I was inversely related to age and ranged from 950 ± 150 ng/l (mean ± S.E.M.) (20–30 years) to 410 ± 70 ng/l (⪢ 60 years). The relative percentage was, however, unchanged, being 0.38 ± 0.02% of total IGF‐I. In contrast, free IGF‐II was independent of age, being 1,480 ± 80 ng/l (∼0.20 ± 0.01% of total IGF‐II).Keywords
This publication has 19 references indexed in Scilit:
- A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.Journal of Clinical Investigation, 1993
- Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humansJournal of Clinical Endocrinology & Metabolism, 1992
- Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.Journal of Clinical Investigation, 1992
- Insulin‐Like Growth Factor (IGF) Binding Proteins: the Role of Serum IGFBPs in Regulating IGF AvailabilityActa Paediatrica, 1991
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsNew England Journal of Medicine, 1987
- Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats.Journal of Clinical Investigation, 1986
- Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studiesAnalytical Biochemistry, 1986
- Ultrafiltration in Serum Protein Binding DeterminationsJournal of Pharmaceutical Sciences, 1981
- Free T4free T3and free reverse T3in dialysates of serum. The influence of electrolytes and pH with special reference to the physiological rangeScandinavian Journal of Clinical and Laboratory Investigation, 1979
- Ultrasensitive Radioimmunoassay for Direct Determination of Free Triiodothyronine Concentration in SerumScandinavian Journal of Clinical and Laboratory Investigation, 1975